Georgia vs Lao People's Democratic Republic: Share of E. coli infections resistant to cephalosporins
Georgia
46.5%
in 2022
Lao People's Democratic Republic
52.6%
in 2022
Georgia rank
18th
Lao People's Democratic Republic rank
16th
Share of E. coli infections resistant to cephalosporins over time
- Georgia
- Lao People's Democratic Republic
How they compare
Lao People's Democratic Republic currently reports 52.6% against 46.5% in Georgia, a difference of 6.1%.
That makes Lao People's Democratic Republic's figure about 1.1 times Georgia's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Georgia ahead.
Georgia ranks 18th and Lao People's Democratic Republic ranks 16th of 46 countries.
Across the 2 decades both report, Georgia averaged higher in 1 and Lao People's Democratic Republic in 1.
Head to head by decade
| Decade | Georgia | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.1% | 46.9% | 6.2% | Georgia |
| 2020s | 41.8% | 49.7% | 7.8% | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Georgia or Lao People's Democratic Republic?
- Lao People's Democratic Republic, at 52.6% against 46.5% in Georgia as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Georgia and Lao People's Democratic Republic?
- 6.1%, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Georgia and Lao People's Democratic Republic?
- 6 years are reported by both, from 2017 to 2022.
- How do Georgia and Lao People's Democratic Republic rank globally for share of e. coli infections resistant to cephalosporins?
- Georgia ranks 18th and Lao People's Democratic Republic ranks 16th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).